The total return over the past 12 months is +18.39% vs. +16.94% for the S&P 500. So far it's up +28.50% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +18.39% | +18.17% | (27.73%) | (21.02%) | N/A | N/A |
| Total Return CAGR | +18.39% | +18.17% | (27.73%) | (21.02%) | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Neurogene Inc. (NGNE)
| Year | Start price | End price | NGNE Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $20.60 | $26.47 | +28.50% | +14.51% | +13.99% |
| 2025 | $22.86 | $20.60 | (9.89%) | +17.72% | (27.61%) |
| 2024 | $19.38 | $22.86 | +17.96% | +24.89% | (6.93%) |
| 2023 | $10.18 | $19.38 | +90.37% | +26.19% | +64.18% |
| 2022 | $96.40 | $10.18 | (89.44%) | (18.17%) | (71.27%) |
| 2021 | $282.00 | $96.40 | (65.82%) | +28.74% | (94.56%) |
| 2020 | $246.40 | $282.00 | +14.45% | +18.37% | (3.92%) |
| 2019 | $43.20 | $246.40 | +470.37% | +31.22% | +439.15% |
| 2018 | $235.20 | $43.20 | (81.63%) | (4.56%) | (77.07%) |
| 2017 | $330.20 | $235.20 | (28.77%) | +21.70% | (50.47%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
